Table 1 Characteristics of participating QCs (= cluster) and GPs (= participants)
| Â | Characteristics | Study arm A ('blended') | Study arm B ('classical') | 'Control' Group (not randomised) |
|---|---|---|---|---|
QCs | Â | 13 | 13 | 4 |
| Â | Sponsored by pharmaceutical industry | 5 | 4 | 0 |
| Â | Training in dementia topics during the last 12 months | 2 | 1 | 1 |
| Â | Meetings per year (median) | 6.7 | 6.5 | 6.5 |
|  | Average time between t0 and t1 in weeks (SD) ('control' group: t2') | 9.5 (± 3.7) | 8.5 (± 4.4) | 21 (± 4.0) |
GPs | Participants (t0 and t1) | 84 | 82 | 21 (t0 and t2') |
|  | Average age of participants in years (SD) | 51 (± 6.8) | 50.7 (± 7.5) | 49.3 (± 8.8) |
| Â | Percentage of females | 29% | 28% | 43% |
| Â | Single doctor practices (versus group practice) | 44% | 51% | 24% |